Biomarker ID | 1761 |
PMID | 30286478 |
Year | 2018 |
Biomarker | CGA (chromogranin A) |
Biomarker Basis | Concentration Based (ng/mL) |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | NA |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.341 (95% CI: 1.011-1.778) |
Effect on Pathways | NA |
Experiment | Progression Free Survival Vs No Progression Free Survival |
Type of Biomarker | Prognostic |
Cohort | 23 patients with CRPC were included in the study. 4 serum collections were not feasable after study. 19 samples were avaliable, with change from baseline. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0416 |
Method Used | NA |
Clinical | Yes |
Remarks | Trial Not registered with NCT but, site: Germanctr.de |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |